Haemonetics (HAE) Deferred Taxes (2017 - 2025)
Haemonetics has reported Deferred Taxes over the past 11 years, most recently at -$2.1 million for Q4 2025.
- For Q4 2025, Deferred Taxes rose 14.69% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$2.6 million, up 81.76%, while the annual FY2025 figure was -$5.2 million, 52.72% up from the prior year.
- Deferred Taxes for Q4 2025 was -$2.1 million at Haemonetics, down from -$725000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $3.4 million in Q1 2025 and troughed at -$15.9 million in Q2 2021.
- A 5-year average of -$2.2 million and a median of -$2.2 million in 2024 define the central range for Deferred Taxes.
- On a YoY basis, Deferred Taxes climbed as much as 593.2% in 2021 and fell as far as 619.72% in 2021.
- Year by year, Deferred Taxes stood at -$121000.0 in 2021, then soared by 2590.91% to $3.0 million in 2022, then crashed by 207.66% to -$3.2 million in 2023, then grew by 25.52% to -$2.4 million in 2024, then grew by 14.69% to -$2.1 million in 2025.
- Business Quant data shows Deferred Taxes for HAE at -$2.1 million in Q4 2025, -$725000.0 in Q3 2025, and -$3.2 million in Q2 2025.